Filing Overview
ADC Therapeutics SA filed a Form 6-K for March 2023 on March 13, 2023. The filing is a report by a foreign private issuer and contains a specific disclosure regarding Silicon Valley Bank.
Key Financial Information
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Disclosure
ADC Therapeutics stated that it does not hold deposits or securities at Silicon Valley Bank.
Outlook, Risks, and Unusual Items
No guidance, outlook, management commentary, contingencies, or other unusual items are provided. The Silicon Valley Bank disclosure appears to address potential exposure to the bank.
Investor Verification Items
- Verify the company’s cash, investments, and banking counterparties in its latest annual report or subsequent filings.
- Confirm whether any exposure to Silicon Valley Bank or other financial institutions arose after the filing date.
- Review subsequent filings for updated liquidity, financing, and operating information.